{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:38:41Z","timestamp":1790473121173,"version":"4.1.0"},"reference-count":59,"publisher":"FapUNIFESP (SciELO)","issue":"1 suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Acad. Bras. Ci\u00eanc."],"DOI":"10.1590\/0001-3765201820170505","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T18:35:12Z","timestamp":1519151712000},"page":"645-661","source":"Crossref","is-referenced-by-count":22,"title":["From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases"],"prefix":"10.1590","volume":"90","author":[{"given":"LEONARDO G.","family":"FERREIRA","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GLAUCIUS","family":"OLIVA","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADRIANO D.","family":"ANDRICOPULO","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s12010-009-8689-6","article-title":"Role of human liver microsomes in in vitro metabolism of drugs-a review","volume":"160","author":"ASHA S","year":"2010","journal-title":"Appl Biochem Biotechnol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/1381612822666151125000550","article-title":"Computer Aided Drug Design: Success and Limitations","volume":"22","author":"BAIG MH","year":"2016","journal-title":"Curr Pharm Des"},{"key":"ref3","first-page":"453","article-title":"Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development","volume":"58","author":"BARANCZEWSKI P","year":"2006","journal-title":"Pharmacol Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2013.10.015","article-title":"Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs","volume":"57","author":"BERGSTR\u00d6M CA","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/cplu.201200038","article-title":"Quantitative structure-activity\/property relationships: the ubiquitous links between cause and effect","volume":"77","author":"BERHANU WM","year":"2012","journal-title":"ChemPlusChem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature08160","article-title":"The genome of the blood fluke Schistosoma mansoni","volume":"460","author":"BERRIMAN M","year":"2009","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1016\/j.bmc.2007.06.021","article-title":"2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors","volume":"15","author":"CASTILHO MS","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bmc.2010.01.022","article-title":"Structural basis for selective inhibition of purine nucleoside phosphorylase from Schistosoma mansoni: Kinetic and structural studies","volume":"18","author":"CASTILHO MS","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"COLLEY DG","year":"2014","journal-title":"Lancet"},{"key":"ref10","series-title":"Enzymes: a practical introduction to structure, mechanism, and data analysis","author":"COPELAND RA","year":"2000"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1590\/S0074-02762011000600001","article-title":"Chronic phase of Chagas disease: why should it be treated? A comprehensive review","volume":"106","author":"COURA JR","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","article-title":"Strategic approaches to optimizing peptide ADME properties","volume":"17","author":"DI L","year":"2015","journal-title":"AAPS J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drudis.2013.06.003","article-title":"Genomics and transcriptomics in drug discovery","volume":"19","author":"DOPAZO J","year":"2014","journal-title":"Drug Discov Today"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1128\/AAC.00436-07","article-title":"A cysteine protease inhibitor cures Chagas\u2019 disease in an immunodeficient-mouse model of infection","volume":"51","author":"DOYLE PS","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002139","article-title":"The Trypanosoma cruzi protease cruzain mediates immune evasion","volume":"7","author":"DOYLE PS","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrd4336","article-title":"The discovery of first-in-class drugs: origins and evolution","volume":"13","author":"EDER J","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.drudis.2016.06.021","article-title":"Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective","volume":"21","author":"FERREIRA LG","year":"2016","journal-title":"Drug Discov Today"},{"key":"ref18","first-page":"30152","article-title":"Targeting cysteine proteases in trypanosomatid disease drug discovery","volume":"S0163-7258","author":"FERREIRA LG","year":"2017","journal-title":"Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.2174\/1568026616666160413124902","article-title":"Advances and Progress in Chagas Disease Drug Discovery","volume":"16","author":"FERREIRA LG","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/jm401709b","article-title":"Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents","volume":"57","author":"FERREIRA RS","year":"2014","journal-title":"J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"FERREIRA LG","year":"2015","journal-title":"Molecules"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/jm100488w","article-title":"Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors","volume":"53","author":"FERREIRA RS","year":"2010","journal-title":"J Med Chem"},{"key":"ref23","first-page":"1016","article-title":"Revisiting the hallmarks of cancer","volume":"7","author":"FOUAD YA","year":"2017","journal-title":"Am J Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2133\/dmpk.25.28","article-title":"Contribution of intestinal cytochrome p450-mediated metabolism to drug-drug inhibition and induction interactions","volume":"25","author":"GALETIN A","year":"2010","journal-title":"Drug Metab Pharmacokinet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The Global Burden of Cancer 2013","volume":"1","author":"GLOBAL BURDEN OF DISEASE CANCER COLLABORATION","year":"2015","journal-title":"JAMA Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1573406411309020002","article-title":"Pharmacokinetic properties and in silico ADME modeling in drug discovery","volume":"9","author":"HON\u00d3RIO KM","year":"2013","journal-title":"Med Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbt.2014.02.010","article-title":"Paclitaxel: biosynthesis, production and future prospects","volume":"31","author":"HOWAT S","year":"2014","journal-title":"N Biotechnol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/scipol\/scs125","article-title":"Pharmaceutical innovation and public policy: The case for a new strategy for drug discovery and development","volume":"40","author":"JULIANO RL","year":"2013","journal-title":"Sci Publ Policy"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1517\/13543776.2015.1051727","article-title":"Podophyllotoxin derivatives: a patent review (2012 - 2014)","volume":"25","author":"KAMAL A","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd4581","article-title":"Predicting drug metabolism: experiment and\/or computation","volume":"14","author":"KIRCHMAIR J","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ncb2996","article-title":"The dynamics of microtubule minus ends in the human mitotic spindle","volume":"16","author":"LECLAND N","year":"2014","journal-title":"Nat Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.pt.2016.08.002","article-title":"Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches","volume":"32","author":"MAFUD AC","year":"2016","journal-title":"Trends Parasitol"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160842","article-title":"Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity","volume":"11","author":"MAGALHAES LG","year":"2016","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005033","article-title":"Estimating the Burden of Chagas Disease in the United States","volume":"10","author":"MANNE-GOEHLER J","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5414\/CN108343","article-title":"Colchicine toxicity in renal patients - Are we paying attention","volume":"86","author":"MEDANI S","year":"2016","journal-title":"Clin Nephrol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/bioinformatics\/btn415","article-title":"PK\/DB: database for pharmacokinetic properties and predictive in silico ADME models","volume":"24","author":"MODA TL","year":"2008","journal-title":"Bioinformatics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.bmcl.2012.02.061","article-title":"Consensus hologram QSAR modeling for the prediction of human intestinal absorption","volume":"22","author":"MODA TL","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","article-title":"Targeting microtubules by natural agents for cancer therapy","volume":"13","author":"MUKHTAR E","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"NEWMAN DJ","year":"2012","journal-title":"Nat Prod"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.drudis.2013.11.008","article-title":"Recombinant protein production in bacterial hosts","volume":"19","author":"OVERTON TW","year":"2014","journal-title":"Drug Discov Today"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4155\/fmc-2016-0236","article-title":"Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors","volume":"9","author":"PAULI I","year":"2017","journal-title":"Future Med Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.actatropica.2010.01.010","article-title":"Crystal structure of Schistosoma purine nucleoside phosphorylase complexed with a novel monocyclic inhibitor","volume":"114","author":"PEREIRA HM","year":"2010","journal-title":"Acta Trop"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1021\/ci100128k","article-title":"Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening","volume":"50","author":"POSTIGO MP","year":"2010","journal-title":"J Chem Inf Model"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1590\/S0103-50532011000300024","article-title":"Enzyme kinetics, structural analysis and molecular modeling studies on a series of Schistosoma mansoni PNP inhibitors","volume":"22","author":"POSTIGO MP","year":"2011","journal-title":"J Braz Chem Soc"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4155\/fmc.12.217","article-title":"Tubulin: an example of targeted chemotherapy","volume":"5","author":"SELIGMANN J","year":"2013","journal-title":"Future Med Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/157340912800492357","article-title":"QSAR and QSPR model interpretation using partial least squares (PLS) analysis","volume":"8","author":"STANTON DT","year":"2012","journal-title":"Curr Comput Aided Drug Des"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4155\/ppa-2016-0038","article-title":"Fostering innovative product development for neglected tropical diseases through partnerships","volume":"5","author":"STARR A","year":"2016","journal-title":"Pharm Pat Anal"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.chembiol.2011.12.013","article-title":"Structural biology and drug discovery of difficult targets: the limits of ligandability","volume":"19","author":"SURADE S","year":"2012","journal-title":"Chem Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2012.236","article-title":"Phenotypic vs. target-based drug discovery for first-in-class medicines","volume":"93","author":"SWINNEY DC","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered","volume":"10","author":"SWINNEY DC","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.chembiol.2011.12.007","article-title":"Established and emerging trends in computational drug discovery in the structural genomics era","volume":"19","author":"TABOUREAU O","year":"2012","journal-title":"Chem Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.drudis.2012.01.017","article-title":"Reactions and enzymes in the metabolism of drugs and other xenobiotics","volume":"17","author":"TESTA B","year":"2012","journal-title":"Drug Discov Today"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.1002\/anie.201208390","article-title":"Schistosomiasis chemotherapy","volume":"52","author":"TH\u00c9TIOT-LAURENT SAL","year":"2013","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jmgm.2009.03.001","article-title":"Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: Molecular modeling, CoMFA and CoMSIA studies","volume":"28","author":"TROSSINI GHG","year":"2009","journal-title":"J Mol Graph Model"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1021\/np3006875","article-title":"Development of a natural products database from the biodiversity of Brazil","volume":"76","author":"VALLI M","year":"2013","journal-title":"J Nat Prod"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4155\/fmc.11.149","article-title":"Drug-permeability and transporter assays in Caco-2 and MDCK cell lines","volume":"3","author":"VOLPE DA","year":"2011","journal-title":"Future Med Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"WANG W","year":"2012","journal-title":"Parasitol Res"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng.1065","article-title":"Whole-genome sequence of Schistosoma haematobium","volume":"44","author":"YOUNG ND","year":"2012","journal-title":"Nat Genet"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature08140","article-title":"The Schistosoma japonicum genome reveals features of host-parasite interplay","volume":"460","author":"ZHOU Y","year":"2009","journal-title":"Nature"}],"container-title":["Anais da Academia Brasileira de Ci\u00eancias"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/aabc\/v90n1s1\/0001-3765-aabc-201820170505.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T19:08:31Z","timestamp":1533150511000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0001-37652018000200645&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":59,"journal-issue":{"issue":"1 suppl 1","published-online":{"date-parts":[[2018]]}},"alternative-id":["S0001-37652018000200645"],"URL":"https:\/\/doi.org\/10.1590\/0001-3765201820170505","relation":{},"ISSN":["1678-2690","0001-3765"],"issn-type":[{"value":"1678-2690","type":"electronic"},{"value":"0001-3765","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,15]]}}}